This lack of effect may be attributed to the impaired activation of the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) pathway due to aging and prolonged diabetes progression (with higher glycemia levels), potentially nullifying quercetin’s cardioprotective effects in older rats [41]. The gene discussed is AKT1; the disease is diabetes mellitus.